Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted radiotherapy using Auger electron emitters

J A O'Donoghue1, T E Wheldon

  • 1Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Physics in Medicine and Biology
|October 1, 1996
PubMed
Summary

Auger therapy uses cytotoxic radionuclides for cancer treatment. Optimizing delivery and using short-lived isotopes are key for effective targeted Auger therapy in combination strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.

Physics in medicine and biology·2011
Same author

A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography.

Medical physics·2003
Same author

Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001
Same author

Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy.

The British journal of radiology·2001
Same author

The effect of tissue-specific growth patterns of target stem cells on the spectrum of tumours resulting from multistage tumorigenesis.

Journal of theoretical biology·2001
Same author

A gene therapy/targeted radiotherapy strategy for radiation cell kill by.

The journal of gene medicine·2001

Area of Science:

  • Nuclear medicine
  • Radiochemistry
  • Oncology

Background:

  • Auger-emitting radionuclides offer high cytotoxicity for cancer therapy.
  • Sub-cellular localization of Auger emitters critically influences biological effects.
  • Targeted Auger therapy requires precise delivery for maximal efficacy.

Purpose of the Study:

  • To review the potential of Auger-emitting radionuclides in cancer therapy.
  • To discuss factors influencing the efficacy of targeted Auger therapy.
  • To explore strategies for optimizing radionuclide targeting and delivery.

Main Methods:

  • Review of mathematical modeling studies on radionuclide properties.
  • Analysis of targeting strategies using DNA precursors, hormones, and growth factors.
  • Consideration of oligonucleotide-based targeting for DNA sequence discrimination.

Main Results:

  • Short-lived Auger emitters (e.g., 123I) show theoretical advantages over long-lived ones (e.g., 125I).
  • Heterogeneity in radionuclide uptake poses a significant limitation to therapeutic outcomes.
  • Various targeting molecules, including DNA analogues and binding agents, are being investigated.

Conclusions:

  • Targeted Auger therapy holds promise for cancer treatment.
  • Optimizing radionuclide half-life and ensuring uniform uptake are crucial.
  • The optimal clinical application is likely as part of a multi-modality approach for specific cancers.

Related Experiment Videos